OGT and acute myeloid leukemia: Resistance to chemotherapy was also associated with increased O-GlcNAcylated protein levels and the OGT-inhibitor OSMI-1 enhanced killing by doxorubicin in HL-60 cells and primary AML cells from patients with recurrent or resistant disease (176).